| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 49 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 49 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 49 |
| 3 | TACROLIMUS | 43 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 43 |
| 5 | TACROLIMUS OINTMENT 0.1% | 43 |
| 6 | FLUDARABINE PHOSPHATE | 37 |
| 7 | MYCOPHENOLATE MOFETIL | 37 |
| 8 | ETOPOSIDE | 25 |
| 9 | PREDNISONE | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOTEPA | 19 | 0.0019 |
| 1 | BUSULFAN | 18 | 0.0011 |
| 2 | FLUDARABINE PHOSPHATE | 37 | 0.0009 |
| 3 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 4 | MYCOPHENOLIC ACID | 14 | 0.0004 |
| 5 | MYCOPHENILIC ACID | 8 | 0.0004 |
| 6 | ETOPOSIDE | 25 | 0.0003 |
| 7 | TACROLIMUS OINTMENT 0.1% | 43 | 0.0003 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 43 | 0.0003 |
| 9 | BARICITINIB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 2 | Topoisomerase Inhibitor [EPC] | 25 | 0.0003 |
| 3 | Alkylating Drug [EPC] | 65 | 0.0003 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Insulin [EPC] | 4 | 0.0001 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 10 | 0.0001 |